Card image cap

Brett Guthrie's Public Statements on Issue: Drugs

Office:

On The Ballot: Running, Republican for U.S. House (KY) - District 2

Current Issue:

Drugs

Current Speech Type:

Letter

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Date Title
04/20/2022 Letter to Xavier Becerra, Secretary of Health and Human Services - E&C Republicans Ask Sec. Becerra About the Staggering Increase in Overdose Deaths
03/11/2022 Letter to Hon. Joseph R. Biden, President of the United States - Guthrie Leads Letter Criticizing President Biden's Misguided Approach to Addressing Deadly Fentanyl
10/23/2020 Letter to Timothy Shea, Acting Administrator of the Drug Enforcement Administration - E&C GOP Leaders Question DEA on Opioid Supply Management
10/14/2020 Letter to the Hon. Stephen Hahn, Commissioner of the Food and Drug Administration - E&C Republican Leaders Press FDA on OxyContin Labeling Change
08/11/2020 Letter to the Hon. Alex Azar, Secretary of the Dept. of Health and Human Services - Bipartisan Committee Leaders Request Information on COVID-19's Impact on Addiction & Overdose Crisis
01/23/2020 Letter to Gene Dodaro, Comptroller General of the Government Accountability Office - Republicans Request GAO to Review Grant Funding to Combat Opioid Crisis
01/13/2020 Letter to Saeed Motahari, President and CEO of Insys Therapeutics, Inc. - Griffith, Energy and Commerce Republicans Press for Answers From Opioid Manufacturers
01/13/2020 Letter to Mark Trudeau, President and CEO of Mallinckrodt Pharmaceuticals - Griffith, Energy and Commerce Republicans Press for Answers From Opioid Manufacturers
01/13/2020 Letter to Craig Landau, President and CEO of Pureau Pharma L.P. - Griffith, Energy and Commerce Republicans Press for Answers From Opioid Manufacturers
10/10/2019 Letter to Mr. Uttam Dhillon, Acting Administrator of the Drug Enforcement Administration - McKinley, Walden, and Guthrie press administration, opioid distributors for update on report recommendations
10/10/2019 Letter to Mr. Steven H. Collis, Chief Executive Officer of AmerisourceBergen, Mr. Michael C. Kaufmann, Chief Executive Officer of Cardinal Health, and Mr. Brian S. Tyler, Ph.D., Chief Executive Officer of McKesson Corporation - McKinley, Walden, and Guthrie press administration, opioid distributors for update on report recommendations
09/19/2019 Letter to the Hon. Ned Sharpless, Acting Commissioner U.S. Food and Drug Administration - Pingree Leads Bipartisan Letter to FDA Urging Legal Pathway for CBD
09/18/2019 Letter to the Hon. Ron DeSantis, Governor of Florida, the Hon. Eric Holcomb, Governor of Indiana, the Hon. Matt Bevin, Governor of Kentucky, the Hon. Janet Mills, Governor of Maine, the Hon. Larry Hogan, Governor of Maryland, the Hon. Charlie Baker, Governor of Massachusetts, Michelle Lujan Grisham, Governor of New Mexico, the Hon. Andrew Cuomo, Governor of New York, the Hon. Roy Cooper, Governor of North Carolina, the Hon. Mike DeWine, Governor of Ohio, the Hon. Kate Brown, Governor of Oregon, the Hon. Tom Wolf, Governor of Pennsylvania, the Hon. Gina Raimondo, Governor of Rhode Island, the Hon. Bill Lee, Governor of Tennessee, the Hon. Jim Justice, Governor of West Virginia, and the Hon. Tony Evers, Governor of Wisconsin - E&C bipartisan leaders seek information from states on use of federal funds to respond to opioid crisis
08/28/2019 Letter to the Hon. Brett Giroir, U.S. Dept. of Health and Human Service's Assistant Secretary for Health - Brett E&C Republicans Press HHS for Update on SUPPORT Act Implementation
06/25/2019 Letter to the Hon. Norma Sharpless, Acting Commissioner of the Food and Drug Administration - Bipartisan E&C Leaders Request FDA Briefing on Opioids
06/13/2019 Letter to Various Federal Agencies - Bipartisan E&C Leaders Request Briefings on Ongoing Threat Posed by Fentanyl from Six Federal Agencies
06/13/2019 Letter to the Hon. Kevin McAleenan, James Carroll, Utlam Dhillon, Megan Brennan, Michael Pompeo, and Norman Sharpless - Bipartisan E&C Leaders Request Briefings on Ongoing Threat Posed by Fentanyl From Six Federal Agencies
05/10/2019 Letter to the Hon. Norma Sharpless, Acting Commissioner of the Food and Drug Administration - Reps. Burgess and Roby Urge Continued FDA Oversight of Mail-Order Abortion Drugs
02/11/2019 Letter to the Hon. Frank Pallone, Jr., the Hon. Anna Eshoo, and the Hon. Diana DeGette - Continuation of Bipartisan Work on Opioids
07/05/2016 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy and Commerce - Refusal to Sign Opioid Conference Report Without Funding to Combat Drug Addiction Epidemic
10/28/2015 Letter to Howard Shelanski, Administrator, Office of Information and Regulatory Affairs - Halt Harmful Opioid Rule
09/22/2014 Letter to Sylvia Mathews Burwell, Secretary of Health and Human Services - Ensure Access to All Available Addiction Therapies
arrow_upward